Your browser doesn't support javascript.
loading
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis.
Knudsen, Maria Højberg; Lindberg, Ulrich; Frederiksen, Jette Lautrup; Vestergaard, Mark Bitsch; Simonsen, Helle Juhl; Varatharaj, Aravinthan; Galea, Ian; Blinkenberg, Morten; Sellebjerg, Finn; Larsson, Henrik Bo Wiberg; Cramer, Stig Præstekjær.
Affiliation
  • Knudsen MH; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B,
  • Lindberg U; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark.
  • Frederiksen JL; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark
  • Vestergaard MB; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark.
  • Simonsen HJ; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark.
  • Varatharaj A; Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, University Road, Southampton SO17 1BJ, United Kingdom; Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Tremona Road, SO16 6YD Southampton, United Kingdom.
  • Galea I; Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, University Road, Southampton SO17 1BJ, United Kingdom; Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Tremona Road, SO16 6YD Southampton, United Kingdom.
  • Blinkenberg M; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark.
  • Sellebjerg F; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark
  • Larsson HBW; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B,
  • Cramer SP; Functional Imaging Unit, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 1-23, 2600 Glostrup, Denmark.
Mult Scler Relat Disord ; 63: 103891, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35661562
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article Country of publication: Países Bajos